View |
|
DRP-1726-02
|
Levofloxacin (as hemihydrate)
|
Lenoflox
|
500 mg
|
Film-coated Tablet
|
Antibacterial (Third Generation Quinolone)
|
The ACME Laboratories Limited
|
Bangladesh
|
CLIDP Conversion
|
03 December 2023
|
19 May 2029
|
View |
|
DRP-2315-02
|
Iron (as fumarate) + Folic Acid + Cyanocobalamin (Vitamin B12)
|
FerroFolate Plus
|
165 mg/800 mcg/3 mcg
|
Capsule
|
Anti-anemic
|
Pharmatechnica Laboratory, Inc.
|
Philippines
|
CLIDP Conversion
|
26 November 2023
|
28 April 2027
|
View |
|
DRP-2672-16
|
Clopidogrel (as bisulfate)
|
None
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic (Platelet Aggregation Inhibitor)
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
03 December 2023
|
04 January 2029
|
View |
|
DRP-2821-10
|
Ambroxol hydrochloride
|
Hydralin
|
15 mg/5 mL
|
Syrup
|
Mucolytic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
03 December 2023
|
23 December 2025
|
View |
|
DRP-2929-01
|
Phenylpropanolamine Hydrochloride
|
Provana
|
12.5 mg/5 mL
|
Syrup
|
Nasal Decongestant
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
03 December 2023
|
15 April 2026
|
View |
|
DRP-3294-05
|
Ascorbic Acid + Zinc
|
Curecee Plus
|
100 mg/10 mg per 5 mL
|
Syrup
|
Vitamin/Mineral
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
13 December 2023
|
03 October 2026
|
View |
|
DRP-3355-07
|
Ambroxol Hydrochloride
|
Hydralin
|
30 mg/ 5 mL
|
Syrup
|
Mucolytic
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
03 December 2023
|
01 August 2026
|
View |
|
DRP-3389-02
|
Ceftazidime (as Pentahydrate)
|
None
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Inject Care Parenterals Pvt. Ltd
|
India
|
CLIDP Conversion
|
08 December 2023
|
10 November 2026
|
View |
|
DRP-3704-07
|
Co-Amoxiclav
|
Clavstan
|
250 mg/ 62.5 mg per 5 mL
|
Powder for Suspension
|
Antibacterials (Penicillin)
|
LLOYD LABORATORIES, INC
|
Philippines
|
CLIDP Conversion
|
03 December 2023
|
21 October 2026
|
View |
|
DRP-3779-04
|
Thiamine Mononitrate (Vitamin B1) + Pyridoxine Hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
None
|
100 mg/5 mg/50 mcg
|
Tablet
|
Vitamins
|
Pharmatechnica Laboratory, Inc
|
Philippines
|
CLIDP Conversion
|
22 November 2023
|
27 April 2026
|
View |
|
DRP-3779-05
|
Thiamine Mononitrate (Vitamin B1) + Pyridoxine Hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
None
|
100 mg/5 mg/50 mcg
|
Tablet
|
Vitamins
|
Pharmatechnica Laboratory, Inc.
|
Philippines
|
CLIDP Conversion
|
14 December 2023
|
27 April 2026
|
View |
|
DRP-3987-02
|
Cetirizine Hydrochloride
|
Accurecin
|
2.5mg/mL
|
Syrup (Oral Drops)
|
Antihistamine (Piperazine derivative)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
03 December 2023
|
13 September 2027
|
View |
|
DRP-424-09
|
Tobramycin + Dexamethasone
|
TodexCare
|
3 mg/1 mg per mL
|
Ophthalmic Suspension
|
Antibacterial (Aminoglycoside) and Corticosteroid in combination
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
13 December 2023
|
05 February 2027
|
View |
|
DRP-4259-04
|
Metronidazole
|
None
|
5mg/mL (0.5% w/v)
|
Solution for IV Infusion
|
Antibacterial (Imidazole Derivative)
|
Akums Drugs and Pharmaceuticals Ltd. (Plant III- Injectables)
|
India
|
CLIDP Conversion
|
26 November 2023
|
08 March 2026
|
View |
|
DRP-4476-02
|
Salbutamol (as sulfate) + Guaifenesin
|
Salbucass
|
2 mg/100 mg
|
Capsule
|
Antiasthma/Expectorant
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
26 November 2023
|
13 June 2028
|
View |
|
DRP-4874-02
|
Etoricoxib
|
None
|
90 mg
|
Film-Coated Tablet
|
Coxib
|
XL Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
14 December 2023
|
29 October 2028
|
View |
|
DRP-4921-03
|
Sertraline (as hydrochloride)
|
Zertrabyn
|
50 mg
|
Film-Coated Tablet
|
Antidepressant (Selective Serotonin Reuptake Inhibitor)
|
Sydler Remedies Pvt. Limited
|
India
|
CLIDP Conversion
|
14 December 2023
|
13 November 2028
|
View |
|
DRP-4968-02
|
Amlodipine (as besilate)
|
None
|
5 mg
|
Tablet
|
Calcium Channel Blocker
|
Ravian Life Science Pvt. Ltd
|
India
|
CLIDP Conversion
|
23 November 2023
|
29 November 2028
|
View |
|
DRP-5026-02
|
Guaifenesin + Salbutamol (as sulfate)
|
Guiasol Plus
|
100 mg/2 mg
|
Capsule
|
Expectorant/Antiasthma
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
28 November 2023
|
27 December 2028
|
View |
|
DRP-5274-02
|
Dicycloverine Hydrochloride
|
Reliefas
|
5 mg / mL
|
Syrup (Oral Drops)
|
Anticholinergic
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
03 December 2023
|
09 July 2027
|